Publication | Closed Access
High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors.
44
Citations
20
References
2009
Year
Dose escalation of S-LAR is well tolerated and may provide longer disease control.
| Year | Citations | |
|---|---|---|
Page 1
Page 1